1. Home
  2. MLEC vs ACXP Comparison

MLEC vs ACXP Comparison

Compare MLEC & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moolec Science SA

MLEC

Moolec Science SA

N/A

Current Price

$0.42

Market Cap

4.9M

Sector

Finance

ML Signal

N/A

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$4.15

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLEC
ACXP
Founded
2008
2017
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
6.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MLEC
ACXP
Price
$0.42
$4.15
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$143.67
AVG Volume (30 Days)
131.7K
79.9K
Earning Date
01-30-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.42
N/A
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
170.36
N/A
52 Week Low
$0.39
$3.17
52 Week High
$8.00
$25.00

Technical Indicators

Market Signals
Indicator
MLEC
ACXP
Relative Strength Index (RSI) 36.36 46.95
Support Level $0.41 $3.98
Resistance Level $0.48 $4.36
Average True Range (ATR) 0.05 0.39
MACD 0.01 0.11
Stochastic Oscillator 24.66 62.89

Price Performance

Historical Comparison
MLEC
ACXP

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Share on Social Networks: